Source: International Congress 2016 – New signalling pathways in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Adam Wright (Leicester, United Kingdom), Adam Wright, Chris Newby, Ruth Hartley, Vijay Mistry, Sumit Gupta, Rachid Berair, Katy Roach, Ruth Saunders, Tracy Thornton, Maria Shelley, Karen Edwards, Bethan Barker, Chris Brightling. Myeloid derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in COPD. Eur Respir J 2016; 48: Suppl. 60, 4009

Member's Comments

No comment yet.

Related content which might interest you: Identification and characterization of mesenchymal stem cells in the human lung Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Myeloid derived suppressor cells in the crosstalk between COPD and lung cancer Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011 Elevated IL-17A in very severe COPD is localized to mast cells and correlates with lung function decline Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 Impaired migration of bone marrow mesenchymal stem cells in COPD Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 B-cell activating factor: The architect of lymphoid follicles in severe COPD Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Alterations of the soluble proteome of airway epithelial cells in COPD Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer? Source: International Congress 2016 – Mechanisms of disease Year: 2016 Myofibroblast expression in airways and alveoli is affected by smoking and COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Deriving type II alveolar cells from pluripotent stem cells to produce a novel model of alpha-1 antitrypsin deficiency pathogenesis Source: International Congress 2016 – Mechanisms of disease Year: 2016 The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Disease specific effects of adrenomedullin in COPD and asthma derived human bronchial epithelial cells Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Mapping of eosinophil and basophils in COPD lung tissues Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Functional comparison of bone-marrow derived mesenchymal stromal cells obtained from COPD patients and non-COPD controls Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 LSC - 2021 - Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 Endothelial progenitor cells are dysfunctional in smokers and COPD patients due to increased DNA damage and senescence Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Epithelial mesenchymal transition (EMT) in the small and large airways of lung cancer patients undergoing thoracotomy Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Bone marrow-derived MSCs from patients with COPD have abnormal functional capacity Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Cigarette smoke alters the EZH2/DAB2IP expression in bronchial epithelial cells. A risk factor for lung cancer in COPD patients Source: International Congress 2016 – Studies in airway cell biology Year: 2016